141 related articles for article (PubMed ID: 6169613)
1. Pathology of cytoskeleton of liver cells: demonstration of mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes.
Denk H; Franke WW; Dragosics B; Zeiler I
Hepatology; 1981; 1(1):9-20. PubMed ID: 6169613
[No Abstract] [Full Text] [Related]
2. Formation and involution of Mallory bodies ("alcoholic hyalin") in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin.
Denk H; Franke WW; Eckerstorfer R; Schmid E; Kerjaschki D
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4112-6. PubMed ID: 386356
[TBL] [Abstract][Full Text] [Related]
3. [Changes in the intermediate filament cytoskeleton of liver cells in alcoholic liver injury].
Denk H; Lackinger E
Wien Klin Wochenschr; 1985 Apr; 97(8):354-8. PubMed ID: 2581375
[TBL] [Abstract][Full Text] [Related]
4. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies.
Preisegger KH; Zatloukal K; Spurej G; Denk H
Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496
[TBL] [Abstract][Full Text] [Related]
5. Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody.
Hazan R; Denk H; Franke WW; Lackinger E; Schiller DL
Lab Invest; 1986 May; 54(5):543-53. PubMed ID: 2422438
[TBL] [Abstract][Full Text] [Related]
6. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse.
Zatloukal K; Spurej G; Rainer I; Lackinger E; Denk H
Hepatology; 1990 Apr; 11(4):652-61. PubMed ID: 1691733
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides.
Franke WW; Denk H; Schmid E; Osborn M; Weber K
Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290
[TBL] [Abstract][Full Text] [Related]
8. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
Kawahara H; Marceau N; French SW
Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
[TBL] [Abstract][Full Text] [Related]
9. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter.
Zatloukal K; Böck G; Rainer I; Denk H; Weber K
Lab Invest; 1991 Feb; 64(2):200-6. PubMed ID: 1705301
[TBL] [Abstract][Full Text] [Related]
10. Immunological and biochemical characterization of the keratin-related component of Mallory bodies: a pathological pattern of hepatocytic cytokeratins.
Denk H; Krepler R; Lackinger E; Artlieb U; Franke WW
Liver; 1982 Sep; 2(3):165-75. PubMed ID: 6184592
[TBL] [Abstract][Full Text] [Related]
11. High molecular weight component of Mallory bodies detected by a monoclonal antibody.
Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW
Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.
Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW
Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice.
Irie T; Benson NC; French SW
Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660
[TBL] [Abstract][Full Text] [Related]
14. On the three-dimensional structure of quick-frozen hepatic Mallory bodies with special reference to the appearance of cytoplasmic vesicles.
Irie T; Koyama W; Ikeuchi Y; Kanaseki T
Cell Struct Funct; 1991 Feb; 16(1):1-16. PubMed ID: 1709594
[TBL] [Abstract][Full Text] [Related]
15. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver.
Katsuma Y; Swierenga SH; Khettry U; Marceau N; French SW
Hepatology; 1987; 7(6):1215-23. PubMed ID: 2445643
[TBL] [Abstract][Full Text] [Related]
16. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver.
Hutter H; Zatloukal K; Winter G; Stumptner C; Denk H
Lab Invest; 1993 Nov; 69(5):576-82. PubMed ID: 7504119
[TBL] [Abstract][Full Text] [Related]
17. Use of a specific monoclonal antibody to detect Mallory bodies in liver disease.
Leevy CB; Sameshima Y; Yoshioka K; Leevy CM; Kanagasundaram N; Unoura M
J Assoc Acad Minor Phys; 1990; 1(2):24-5, 28-30. PubMed ID: 2135694
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of desmosomes in mouse hepatocytes after drug-induced rearrangement of cytokeratin filament material. Demonstration of independence of desmosomes and intermediate-sized filaments.
Denk H; Lackinger E; Cowin P; Franke WW
Exp Cell Res; 1985 Nov; 161(1):161-71. PubMed ID: 2414118
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay.
Kachi K; Cadrin M; French SW
Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660
[TBL] [Abstract][Full Text] [Related]
20. Electron microscopic study of the in vitro calcium-dependent degradation of Mallory bodies and intermediate filaments in hepatocytes.
Irie T; Benson NC; French SW
Lab Invest; 1984 Mar; 50(3):303-12. PubMed ID: 6199585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
